Changes in urinary albumin:creatinine ratio (UACR), as well as estimated glomerular filtration rate (eGFR), are commonly used as surrogate endpoints in chronic kidney disease (CKD) clinical trials [2, 3] and recognized as important risk factors for cardiovascular disease [4, 5]. Here, ALB is linked to chronic kidney disease.